The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Regulatory News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

19 Dec 2018 10:51

RNS Number : 9789K
GoldmanSachs International
19 December 2018
 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

(GS) GOLDMAN SACHS INTERNATIONAL

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

SHIRE PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

SHIRE PLC

(d) Date dealing undertaken:

18 December 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES - disclosed previously for TAKEDA PHARMACEUTICAL COMPANY LIMITED

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary

Purchases

2,778,997109,857

44.1900 GBP55.6424 USD

43.2800 GBP54.8140 USD

Ordinary

Sales

3,874,36990,001

44.1600 GBP56.1723 USD

43.2900 GBP55.2932 USD

ADR / (1.00 : 3.00)

Purchases

7,825 (23,475)

166.3000 USD

165.8232 USD

ADR / (1.00 : 3.00)

Sales

7,825 (23,475)

165.9925 USD

165.6878 USD

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Ordinary

CFD

Reducing a long position

15,925

43.3728 GBP

Ordinary

CFD

Reducing a short position

2,287

43.7100 GBP

Ordinary

CFD

Opening a long position

15,925

43.7768 GBP

Ordinary

CFD

Opening a short position

2,287

43.7994 GBP

Ordinary

CFD

Opening a short position

6,072

43.8032 GBP

Ordinary

CFD

Reducing a short position

23

43.8333 GBP

Ordinary

CFD

Opening a long position

2,000

43.8484 GBP

Ordinary

CFD

Opening a long position

50,000

43.8617 GBP

Ordinary

CFD

Increasing a short position

662

43.8663 GBP

Ordinary

CFD

Reducing a long position

2,000

43.8747 GBP

Ordinary

CFD

Reducing a long position

39

43.9296 GBP

Ordinary

CFD

Reducing a long position

44,961

43.9296 GBP

Ordinary

CFD

Increasing a long position

652

43.9547 GBP

Ordinary

CFD

Reducing a long position

1,440

44.0000 GBP

Ordinary

CFD

Opening a short position

2,928

44.0000 GBP

Ordinary

CFD

Reducing a long position

885

44.0035 GBP

Ordinary

CFD

Reducing a long position

2,320

44.0035 GBP

Ordinary

CFD

Reducing a long position

134

44.0035 GBP

Ordinary

CFD

Reducing a long position

2,078

44.0035 GBP

Ordinary

CFD

Reducing a long position

449

44.0035 GBP

Ordinary

CFD

Reducing a long position

560

44.0035 GBP

Ordinary

CFD

Opening a short position

642

54.8140 USD

Ordinary

CFD

Opening a short position

286

54.8140 USD

Ordinary

CFD

Opening a short position

71

54.8140 USD

Ordinary

CFD

Opening a short position

3,259

55.0113 USD

Ordinary

CFD

Opening a short position

1,595

55.0113 USD

Ordinary

CFD

Opening a short position

200

55.0113 USD

Ordinary

CFD

Opening a short position

733

55.0113 USD

Ordinary

CFD

Reducing a short position

1

55.2932 USD

Ordinary

CFD

Opening a short position

20,571

55.3421 USD

Ordinary

CFD

Increasing a short position

20,000

55.4263 USD

Ordinary

CFD

Increasing a short position

1,615

55.5176 USD

Ordinary

CFD

Increasing a short position

26,265

55.5176 USD

Ordinary

CFD

Increasing a short position

14,620

55.5176 USD

Ordinary

SWAP

Reducing a long position

25,000

43.6005 GBP

Ordinary

SWAP

Reducing a long position

25,000

43.6055 GBP

Ordinary

SWAP

Reducing a short position

10,840

43.8262 GBP

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Purchasing

10 (3,000)

175.0000 USD

AMERICAN

01/02/2019

2.2080 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Purchasing

10 (3,000)

175.0000 USD

AMERICAN

01/02/2019

2.3500 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Purchasing

5 (1,500)

175.0000 USD

AMERICAN

01/02/2019

2.1020 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Purchasing

5 (1,500)

175.0000 USD

AMERICAN

01/02/2019

2.8520 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Purchasing

10 (3,000)

175.0000 USD

AMERICAN

01/02/2019

2.7570 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

3 (900)

162.5000 USD

AMERICAN

01/02/2019

7.8000 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

10 (3,000)

165.0000 USD

AMERICAN

01/02/2019

6.7400 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

10 (3,000)

165.0000 USD

AMERICAN

01/02/2019

6.8620 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

10 (3,000)

165.0000 USD

AMERICAN

01/02/2019

7.2480 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

5 (1,500)

165.0000 USD

AMERICAN

01/02/2019

6.9440 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

5 (1,500)

165.0000 USD

AMERICAN

01/02/2019

7.3000 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

3 (900)

170.0000 USD

AMERICAN

28/12/2018

1.1000 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

5 (1,500)

172.5000 USD

AMERICAN

01/02/2019

2.8500 USD

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising / exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

19 December 2018

Contact name:

Kashif Rafiq and Papa Lette

Telephone number:

+44(20) 7051 0547 / +44(20) 7774 7442

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERBGBDDISBBGIC
Date   Source Headline
8th Jan 20195:30 pmGNWDirector/PDMR Shareholding
8th Jan 20193:20 pmRNSForm 8.3 - Shire plc
8th Jan 20193:19 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20193:13 pmRNSForm 8.3 - Shire plc
8th Jan 20193:07 pmRNSForm 8.5 (EPT/NON-RI)
8th Jan 20192:28 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:23 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:21 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20191:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20191:27 pmRNSForm 8.3 - Shire plc
8th Jan 201912:31 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201912:29 pmRNSForm 8.3 - Takeda Pharmaceutical
8th Jan 201912:27 pmRNSForm 8.3 - Shire plc
8th Jan 201911:42 amRNSForm 8.5 (EPT/NON-RI)
8th Jan 201911:33 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
8th Jan 201910:49 amRNSForm 8.5 (EPT/RI)
8th Jan 201910:41 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201910:26 amRNSForm 8.5 (EPT/RI)- Shire plc
8th Jan 20199:51 amRNSForm 8.3 - Shire Plc
8th Jan 20198:44 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
8th Jan 20197:00 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20197:00 amGNWScheme becomes effective
7th Jan 20195:00 pmGNWHolding(s) in Company
7th Jan 20193:42 pmRNSForm 8.5 (EPT/RI) - Amendment
7th Jan 20193:20 pmRNSForm 8.3 - Shire plc
7th Jan 20193:02 pmRNSForm 8.3 - Shire plc
7th Jan 20193:00 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 20193:00 pmRNSForm 8.3 - Shire plc
7th Jan 20192:59 pmRNSForm 8.3 - Takeda Pharmaceutical
7th Jan 20192:50 pmPRNForm 8.3 - Shire Plc
7th Jan 20192:49 pmRNSForm 8.3 - Shire plc
7th Jan 20192:47 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20192:45 pmBUSForm 8.3 - Shire plc
7th Jan 20191:55 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20191:54 pmRNSForm 8.3 - Shire plc
7th Jan 20191:39 pmRNSForm 8.3 - [Shire Plc]
7th Jan 20191:32 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 20191:29 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 201912:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201912:56 pmRNSForm 8.3 - Shire plc
7th Jan 201912:42 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 201911:52 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:43 amBUSForm 8.3 - SHIRE PLC
7th Jan 201911:30 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:27 amRNSForm 8.3 - Shire plc
7th Jan 201911:01 amRNSForm 8.5 (EPT/RI)- Shire plc
7th Jan 201910:59 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
7th Jan 201910:35 amRNSForm 8.5 - Shire plc
7th Jan 201910:16 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
7th Jan 201910:13 amRNSForm 8.5 (EPT/RI) - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.